Randomized, Double-Blind, Phase III Trial of Ipilimumab Versus Placebo in Asymptomatic or Minimally Symptomatic Patients With Metastatic Chemotherapy-Naive Castration-Resistant Prostate Cancer. (Q46007871)
Jump to navigation
Jump to search
scientific article published on 31 October 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Randomized, Double-Blind, Phase III Trial of Ipilimumab Versus Placebo in Asymptomatic or Minimally Symptomatic Patients With Metastatic Chemotherapy-Naive Castration-Resistant Prostate Cancer. |
scientific article published on 31 October 2016 |
Statements
1 reference
Randomized, Double-Blind, Phase III Trial of Ipilimumab Versus Placebo in Asymptomatic or Minimally Symptomatic Patients With Metastatic Chemotherapy-Naive Castration-Resistant Prostate Cancer. (English)
1 reference
Karim Fizazi
1 reference
Fred Saad
1 reference
Tomasz M Beer
1 reference
Christopher Logothetis
1 reference
Eugene D Kwon
1 reference
Charles G Drake
1 reference
Gwenaelle Gravis
1 reference
Vinod Ganju
1 reference
Jonathan Polikoff
1 reference
Piotr Humanski
1 reference
Josep M Piulats
1 reference
Pablo Gonzalez Mella
1 reference
Siobhan S Ng
1 reference
Dirk Jaeger
1 reference
Francis X Parnis
1 reference
Fabio A Franke
1 reference
Javier Puente
1 reference
Roman Carvajal
1 reference
Lisa Sengeløv
1 reference
M Brent McHenry
1 reference
Arvind Varma
1 reference
Alfonsus J van den Eertwegh
1 reference
Winald Gerritsen
1 reference
31 October 2016
1 reference
35
1 reference
1
1 reference
40-47
1 reference